Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States

被引：0
|
作者：
Kansal, Anuraag R.
Cowie, Martin
Kielhorn, Adrian
Krotneva, Stanimira
Taffazzoli, Ali
Zheng, Ying
Yurgin, Nicole
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
cost effectiveness; systolic chronic heart failure; ivabradine; quality-adjusted life years; hospitalization;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17655
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [1] Cost-Effectiveness of Ivabradine for Heart Failure in the United States
    Kansal, Anuraag R.
    Cowie, Martin R.
    Kielhorn, Adrian
    Krotneva, Stanimira
    Tafazzoli, Ali
    Zheng, Ying
    Yurgin, Nicole
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (05):
  • [2] Cost-Effectiveness of Ivabradine in the Treatment of Chronic Heart Failure
    Adena, Michael A.
    Hamann, Gary
    Sindone, Andrew P.
    HEART LUNG AND CIRCULATION, 2019, 28 (03): : 414 - 422
  • [3] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE IN IRAN
    Taheri, S.
    Aivazi, A.
    Rasekh, H. R.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A617
  • [4] COST-EFFECTIVENESS OF IVABRADINE IN THE TREATMENT OF CHRONIC HEART FAILURE FROM THE MEXICAN PERSPECTIVE
    Constanzo, A. E.
    Rodriguez-Mendoza, M. M.
    Sanchez-Trejo, K.
    VALUE IN HEALTH, 2017, 20 (09) : A613 - A614
  • [5] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN CHRONIC HEART FAILURE IN THE POLISH SETTING
    Borowiec, L.
    Faluta, T.
    Filipiak, K. J.
    Niewada, M.
    Wrona, W.
    VALUE IN HEALTH, 2013, 16 (07) : A528 - A529
  • [6] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN
    Taheri, Saeed
    Heidari, Elham
    Aivazi, Mohammad Ali
    Shams-Beyranvand, Mehran
    Varmaghani, Mehdi
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 576 - 583
  • [7] COST-EFFECTIVENESS OF IVABRADINE IN THAI HEART FAILURE PATIENT
    Vichairuangthum, K.
    Yodla, P.
    Sakthong, P.
    VALUE IN HEALTH, 2012, 15 (07) : A372 - A372
  • [8] THE COST-EFFECTIVENESS OF BETABLLOCKERS IN THE TREATMENT OF CHRONIC HEART FAILURE
    Lezha, Mimoza
    Miraci, Mirela
    Deliana, Artan
    Zera, Eliverta
    Temali, Indrit
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 : S59 - S60
  • [9] A model to assess the cost-effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine
    Iliza, Ange C.
    Matteau, Alexis
    Guertin, Jason R.
    Mitchell, Dominic
    Fanton-Aita, Fiorella
    Dubois, Anick
    Dube, Marie-Pierre
    Tardif, Jean-Claude
    LeLorier, Jacques
    PHARMACOGENOMICS, 2016, 17 (15) : 1693 - 1706
  • [10] A cost-effectiveness analysis of candesartan in the treatment of chronic heart failure
    Lamotte, M
    Annemans, L
    Schockaert, B
    VALUE IN HEALTH, 2005, 8 (06) : A3 - A3
12345